Pharmaceutical Product Development Inc.(PPDI), a contract research organization,Tuesday, reported a decline in profit for the third quarter compared to last year, hurt by lower sales. The company also lowered its guidance for the full-year 2009.
PPD's net income for the quarter declined to $37.7 million or $0.32 per share from $51.2 million or $0.43 per share in the prior-year period. Income from continuing operations was $37.7 million or $0.32 per share, compared with $50.5 million or $0.42 per share in same quarter last year.
On average, 11 analysts polled by Thomson Reuters expected the company to report earnings of $0.32 per share. Analysts' estimates typically exclude one-time items.
Total revenue for the quarter declined to $341.1 million from $394.1 million in the year-ago period. Ten Wall Street analysts expected revenues of $334.16 million for the quarter.
Segment-wise, development segment net sales declined to $315.8 million from $358.7 million and discovery sciences segment net sales, including a milestone payment from Takeda Pharmaceutical Co. Ltd., decreased to $1.1 million from $3.4 million in the year-ago period.
Income from operations was down to $46.9 million from $69.9 million in the previous year quarter.
For the nine months, net income was $140.30 million or $1.18 per share, compared with $140.32 million or $1.16 per share last year. Income from continuing operations decreased to $120.63 million or $1.02 per share from $138.63 million or $1.15 per share in the prior-year. Revenue was $1.06 billion, down from $1.19 billion last year. Looking forward to the full-year, the company said it expects earnings in the range of $1.38 to $1.40 per share, compared to previous range of $1.54 to $1.60 per share. Net revenue is estimated to range from $1.29 billion to $1.31 billion, compared with earlier forecast in the range of $1.39 billion to $1.47 billion. Analysts expect earnings of $1.34 per share on revenues of $1.34 billion.
PPD closed Tuesday's regular at $23.36, up $0.34 or 1.48% on a volume of 1.57 million shares while in after hours trading PPD is up by $0.04 or 0.17% at $23.40 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.